EP1865777A4 - Compositions de stannsoporfine et administration - Google Patents

Compositions de stannsoporfine et administration

Info

Publication number: EP1865777A4
Authority: EP; European Patent Office
Prior art keywords: stannsoporfin; administration; compositions; stannsoporfin compositions
Prior art date: 2005-04-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06749109A

Other languages

German (de)

English (en)

Other versions

EP1865777A2 (fr

Inventor

Philip C Lang

George S Drummond

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Infacare Pharmaceutical Corp

Original Assignee

Infacare Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-01

Filing date

2006-03-31

Publication date

2008-07-16

2005-04-01 Priority claimed from US11/096,359 external-priority patent/US20060222668A1/en

2006-03-31 Application filed by Infacare Pharmaceutical Corp filed Critical Infacare Pharmaceutical Corp

2006-03-31 Priority to EP10014149A priority Critical patent/EP2301548A1/fr

2007-12-19 Publication of EP1865777A2 publication Critical patent/EP1865777A2/fr

2008-07-16 Publication of EP1865777A4 publication Critical patent/EP1865777A4/fr

Status Withdrawn legal-status Critical Current

Links

LLDZJTIZVZFNCM-UHFFFAOYSA-J 3-[18-(2-carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;dichlorotin(2+) Chemical compound [H+].[H+].[Cl-].[Cl-].[Sn+4].[N-]1C(C=C2C(=C(C)C(=CC=3C(=C(C)C(=C4)N=3)CC)[N-]2)CCC([O-])=O)=C(CCC([O-])=O)C(C)=C1C=C1C(C)=C(CC)C4=N1 LLDZJTIZVZFNCM-UHFFFAOYSA-J 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229950001307 stannsoporfin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP06749109A 2005-04-01 2006-03-31 Compositions de stannsoporfine et administration Withdrawn EP1865777A4 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
EP10014149A EP2301548A1 (fr)	2005-04-01	2006-03-31	Compositions de stannsoporfine et administration

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/096,359 US20060222668A1 (en)	2005-04-01	2005-04-01	Stannsoporfin compositions, drug products and methods of manufacture
US11/239,769 US20060222669A1 (en)	2005-04-01	2005-09-30	Stannsoporfin compositions and administration
PCT/US2006/012185 WO2006107806A2 (fr)	2005-04-01	2006-03-31	Compositions de stannsoporfine et administration

Publications (2)

Publication Number	Publication Date
EP1865777A2 EP1865777A2 (fr)	2007-12-19
EP1865777A4 true EP1865777A4 (fr)	2008-07-16

Family

ID=37073987

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06749109A Withdrawn EP1865777A4 (fr)	2005-04-01	2006-03-31	Compositions de stannsoporfine et administration

Country Status (6)

Country	Link
EP (1)	EP1865777A4 (fr)
KR (1)	KR20080004531A (fr)
AU (1)	AU2006232330A1 (fr)
CA (1)	CA2602794A1 (fr)
NO (1)	NO20075508L (fr)
WO (1)	WO2006107806A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7375216B2 (en)	2002-06-04	2008-05-20	Infacare Pharmaceutical Corporation	Preparation of metal mesoporphyrin compounds
US7960371B2 (en)	2006-10-04	2011-06-14	Infacare Pharmaceutical Corporation	High-purity large-scale preparation of stannsoporfin
PL2691398T3 (pl)	2011-03-30	2017-07-31	Infacare Pharmaceutical Corporation	Sposoby syntezy mezoporfiryn metali

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4692440A (en) *	1985-03-25	1987-09-08	The Rockefeller University	Therapeutic use of tin mesoporphyrin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4657902A (en) *	1985-03-25	1987-04-14	The Rockefeller University	Therapeutic use of tin mesoporphyrin
US7375216B2 (en) *	2002-06-04	2008-05-20	Infacare Pharmaceutical Corporation	Preparation of metal mesoporphyrin compounds
US20040097481A1 (en) *	2002-11-20	2004-05-20	Benjamin Levinson	Water-soluble mesoporphyrin compounds and methods of preparation

2006
- 2006-03-31 EP EP06749109A patent/EP1865777A4/fr not_active Withdrawn
- 2006-03-31 KR KR1020077024891A patent/KR20080004531A/ko not_active Ceased
- 2006-03-31 WO PCT/US2006/012185 patent/WO2006107806A2/fr not_active Ceased
- 2006-03-31 CA CA002602794A patent/CA2602794A1/fr not_active Abandoned
- 2006-03-31 AU AU2006232330A patent/AU2006232330A1/en not_active Abandoned
2007
- 2007-10-31 NO NO20075508A patent/NO20075508L/no not_active Application Discontinuation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4692440A (en) *	1985-03-25	1987-09-08	The Rockefeller University	Therapeutic use of tin mesoporphyrin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHENOUDA MAGDY ET AL: "The pharmacokinetics (PK) of stannsoporfin in healthy adult volunteers are dose-proportionate", JOURNAL OF CLINICAL PHARMACOLOGY, vol. 44, no. 10, October 2004 (2004-10-01), & 33RD ANNUAL MEETING OF THE AMERICAN-COLLEGE-OF-CLINICAL-PHARMACOLOGY; PHOENIX, AZ, USA; OCTOBER 03 -05, 2004, pages 1186, XP008092154, ISSN: 0091-2700 *

Also Published As

Publication number	Publication date
WO2006107806A2 (fr)	2006-10-12
AU2006232330A1 (en)	2006-10-12
WO2006107806A3 (fr)	2007-07-12
CA2602794A1 (fr)	2006-10-12
NO20075508L (no)	2007-10-31
KR20080004531A (ko)	2008-01-09
EP1865777A2 (fr)	2007-12-19

Legal Events

Date	Code	Title	Description
2007-11-16	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-12-19	17P	Request for examination filed	Effective date: 20071005
2007-12-19	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2007-12-19	AX	Request for extension of the european patent	Extension state: AL BA HR MK YU
2008-02-06	RAX	Requested extension states of the european patent have changed	Extension state: YU Payment date: 20071025 Extension state: MK Payment date: 20071025 Extension state: HR Payment date: 20071025 Extension state: BA Payment date: 20071025 Extension state: AL
2008-03-26	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/555 20060101AFI20080219BHEP
2008-07-09	RAX	Requested extension states of the european patent have changed	Extension state: YU Payment date: 20071025 Extension state: MK Payment date: 20071025 Extension state: HR Payment date: 20071025 Extension state: BA Payment date: 20071025
2008-07-16	A4	Supplementary search report drawn up and despatched	Effective date: 20080616
2008-07-16	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 1/16 20060101ALI20080610BHEP Ipc: A61K 9/08 20060101ALI20080610BHEP Ipc: A61K 31/555 20060101AFI20080219BHEP
2008-10-15	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: INFACARE PHARMACEUTICAL CORPORATION
2008-11-07	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1114536 Country of ref document: HK
2008-11-26	17Q	First examination report despatched	Effective date: 20081030
2011-03-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
2011-04-27	18W	Application withdrawn	Effective date: 20110314
2014-10-31	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1114536 Country of ref document: HK

Publication	Publication Date	Title
IL190292A (en)	2017-01-31	History of pyridopyrimidinone and their pharmaceutical preparations
IL223545A0 (en)	2013-02-03	Pharmaceutical compositions
IL179809A0 (en)	2007-05-15	Pharmaceutical compositions
GB0408308D0 (en)	2004-05-19	Pharmaceutical compositions
EP2056835A4 (fr)	2013-01-30	Compositions pharmaceutiques et leurs utilisations
IL191072A0 (en)	2008-12-29	Therapeutic compositions and methods
PT1883665T (pt)	2017-11-14	Composições polilactídeo e usos das mesmas
EP1909780A4 (fr)	2012-03-07	Medicaments antituberculeux: compositions et methodes
IL183986A0 (en)	2007-10-31	Pharmaceutical compounds and compositions
ZA200704295B (en)	2008-08-27	Arthrospira-based compositions and uses thereof
EP1890677A4 (fr)	2013-01-30	Compositions pharmaceutiques et leur utilisation
PL1837019T3 (pl)	2013-02-28	Kompozycja farmaceutyczna rozpadająca się w ustach
IL186337A0 (en)	2008-01-20	Stannsoporfin compositions and administration
EP1805154A4 (fr)	2009-11-25	Compositions pharmaceutiques
PT2474528E (pt)	2014-10-28	Compostos antineoplásicos e composições farmacêuticas dos mesmos
EP1865777A4 (fr)	2008-07-16	Compositions de stannsoporfine et administration
GB0407351D0 (en)	2004-05-05	Pharmaceutical compositions
GB0501348D0 (en)	2005-03-02	Compositions and methods
GB0400971D0 (en)	2004-02-18	Pharmaceutical compositions
GB0517043D0 (en)	2005-09-28	Improvements in pharmaceutical compositions
GB0411502D0 (en)	2004-06-23	Pharmaceutical compositions
GB0502792D0 (en)	2005-03-16	Pharmaceutical compositions
GB0514259D0 (en)	2005-08-17	Pharmaceutical compositions
HK1114536A (en)	2008-11-07	Stannsoporfin compositions and administration
GB0508760D0 (en)	2005-06-08	New analgesic compositions and their administration